These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9641650)
1. Amount of Helicobacter pylori in gastric mucus during anti-H. pylori treatment. Furuta T; Takashima M; Futami H; Arai H; Hanai H; Kaneko E J Gastroenterol Hepatol; 1998 May; 13(5):511-5. PubMed ID: 9641650 [TBL] [Abstract][Full Text] [Related]
2. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer]. Kayser S; Flury R; Zbinden R; Fried M; Wirth HP Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483 [TBL] [Abstract][Full Text] [Related]
3. Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori. Ishibashi S; Iwakiri R; Shimoda R; Ootani H; Kawasaki S; Tadano J; Kikkawa A; Ootani A; Oda K; Fujise T; Yoshida T; Tsunada S; Sakata H; Fujimoto K Helicobacter; 2002 Aug; 7(4):245-9. PubMed ID: 12165032 [TBL] [Abstract][Full Text] [Related]
4. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185 [TBL] [Abstract][Full Text] [Related]
5. Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients. Kato M; Asaka M; Kudo M; Sukegawa M; Katagiri M; Koshiyama T; Kagaya H; Nishikawa K; Hokari K; Takeda H; Sugiyama T Aliment Pharmacol Ther; 1996 Oct; 10(5):821-7. PubMed ID: 8899093 [TBL] [Abstract][Full Text] [Related]
6. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer. Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322 [TBL] [Abstract][Full Text] [Related]
7. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980 [TBL] [Abstract][Full Text] [Related]
8. Age-dependent eradication of Helicobacter pylori with dual therapy. Treiber G; Ammon S; Klotz U Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480 [TBL] [Abstract][Full Text] [Related]
9. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. Ahuja V; Dhar A; Bal C; Sharma MP Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815 [TBL] [Abstract][Full Text] [Related]
10. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer? Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin. Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531 [TBL] [Abstract][Full Text] [Related]
12. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori. Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324 [TBL] [Abstract][Full Text] [Related]
15. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [TBL] [Abstract][Full Text] [Related]
16. [Erradicating treatment of Helicobacter pylori with lansoprazole and amoxicillin in duodenal ulcer patients]. Gisbert JP; Boixeda D; Alvarez Baleriola I; Martín de Argila C; Bermejo F; Aller R Rev Clin Esp; 1996 Sep; 196(9):588-93. PubMed ID: 8966319 [TBL] [Abstract][Full Text] [Related]
17. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Spinzi GC; Bierti L; Bortoli A; Colombo E; Fertitta AM; Lanzi GL; Venturelli R; Minoli G Aliment Pharmacol Ther; 1998 May; 12(5):433-8. PubMed ID: 9663722 [TBL] [Abstract][Full Text] [Related]
18. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone. Suzuki M; Kitahora T; Nagahashi S; Suzuki H; Mori M; Hibi T; Ishii H J Clin Gastroenterol; 1998; 27 Suppl 1():S183-6. PubMed ID: 9872519 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication. Suzuki M; Mori M; Miyayama A; Iwai N; Tsunematsu N; Oonuki M; Suzuki H; Hibi T; Ishii H J Clin Gastroenterol; 1997; 25 Suppl 1():S222-8. PubMed ID: 9479652 [TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of lansoprazole-amoxicillin treatment in eradicating Helicobacter pylori: evaluation by the polymerase chain reaction method. Shimada T; Ogura K; Ota S; Terano A J Clin Gastroenterol; 1995; 20 Suppl 2():S100-3. PubMed ID: 7594321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]